Trial Profile
Strontium ranelate for the prevention of nonvertebral fracture in women with postmenopausal osteoporosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Jan 2014
Price :
$35
*
At a glance
- Drugs Strontium ranelate (Primary)
- Indications Fracture; Postmenopausal osteoporosis
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms TROPOS
- 05 Nov 2010 New trial record.